Gressens SB, Wiedemann A, Dechenaud M, Dupuis J, et al. Anti-SARS-CoV-2 cellular response after 2 and 3 doses of BNT162b2 mRNA vaccine in lymphoma patients receiving anti-CD20 antibodies. Vaccine 2023 Jan 30:S0264-410X(23)00095-6. doi: 10.1016/j.vaccine.2023.
PMID: 36737320